论文部分内容阅读
目的:研究分析尼莫地平用于治疗偏头痛的临床疗效。方法:将66例偏头痛患者随机分为A组与B组,A组应用尼莫地平治疗,B组应用氟桂利嗪治疗,比较两组的疗效。结果:A组治疗总有效率100%,与B组的93.94%无明显差异(P>0.05);两组治疗后头痛发作次数以及持续时间均显著降低(P<0.05),两组间无明显差异(P>0.05);A组不良反应率为6.06%,显著低于B组的21.21%(P<0.05)。结论:尼莫地平用于治疗偏头痛疗效显著,不良反应较少,值得推广应用。
Objective: To study the clinical efficacy of nimodipine in the treatment of migraine. Methods: Sixty-six patients with migraine were randomly divided into group A and group B, group A was treated with nimodipine, group B was treated with flunarizine, and the curative effect was compared between the two groups. Results: The total effective rate in group A was 100%, which was not significantly different from that in group B (93.94%) (P> 0.05). The number and duration of headache attacks were significantly lower in both groups (P <0.05) (P> 0.05). The adverse reaction rate in group A was 6.06%, which was significantly lower than that in group B (21.21%, P <0.05). Conclusion: The effect of nimodipine for the treatment of migraine is significant, with fewer adverse reactions, which is worth popularizing and applying.